½ÃÀ庸°í¼­
»óǰÄÚµå
1507310

¼¼°èÀÇ ¸ð¹ÙÀÏ ½ÉÀå ÅÚ·¹¸ÞÆ®¸® ½Ã½ºÅÛ ½ÃÀå ±Ô¸ð Á¶»ç : ÃÖÁ¾ ¿ëµµº°, Áö¿ªº° ¿¹Ãø(2022-2032³â)

Global Mobile Cardiac Telemetry Systems Market Size study, by Application (Lead based, Patch Based) by End-use (Hospitals, Cardiac centers, Others) and Regional Forecasts 2022-2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Bizwit Research & Consulting LLP | ÆäÀÌÁö Á¤º¸: ¿µ¹® 200 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ ¸ð¹ÙÀÏ ½ÉÀå ÅÚ·¹¸ÞÆ®¸® ½Ã½ºÅÛ ½ÃÀåÀº 2023³â¿¡ ¾à 10¾ï 4,772¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, ¿¹Ãø ±â°£ 2024-2032³â¿¡´Â 12.72% ÀÌ»óÀÇ °ß½ÇÇÑ ¼ºÀå·ü·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.

¸ð¹ÙÀÏ ½ÉÀå ÅÚ·¹¸ÞÆ®¸®(MCT) ½Ã½ºÅÛÀº ¿À·§µ¿¾È »ç¶÷ÀÇ ½ÉÀå Ȱµ¿À» Áö¼ÓÀûÀ¸·Î ¸ð´ÏÅ͸µÇÏ°í ºÒ±ÔÄ¢ÇÑ ¸®µë ¹× ±âŸ ½ÉÀå À̺¥Æ®¸¦ °¨ÁöÇÏ´Â ¿þ¾î·¯ºí ÀåºñÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ¼ÒÇü Àåºñ´Â ÀÇ·á Á¦°ø¾÷ü¿¡°Ô ¹«¼±À¸·Î µ¥ÀÌÅ͸¦ Àü¼ÛÇϰí ÀÇ·á Á¦°ø¾÷ü´Â ÀÌ»ó ¿©ºÎ¸¦ ºÐ¼®ÇÕ´Ï´Ù. MCT ½Ã½ºÅÛÀº ½É¹æ ¼¼µ¿°ú °°Àº ½ÉÀå ÁúȯÀÇ Áø´Ü°ú °ü¸®¿¡ ¸Å¿ì Áß¿äÇϸç ȯÀÚ¿¡°Ô ½Ç½Ã°£ ¸ð´ÏÅ͸µ°ú Àû½Ã °³ÀÔÀ» Á¦°øÇÕ´Ï´Ù. ÇコÄÉ¾î »ýŰè¿ÍÀÇ ÅëÇÕÀÌ ÁøÇàµÇ°í ÀÖ´Â °ÍÀº ¼¼°èÀÇ ¸ð¹ÙÀÏ ½ÉÀå ÅÚ·¹¸ÞÆ®¸® ½Ã½ºÅÛ ½ÃÀåÀÇ ¼ºÀåÀ» Áö¿øÇÏ´Â Áß¿äÇÑ µ¿ÇâÀÔ´Ï´Ù. MCT ½Ã½ºÅÛÀº ÀüÀÚ ÀÇ·á±â±â(EHR), ¿ø°Ý ÀÇ·á Ç÷§Æû, ¿þ¾î·¯ºí ±â¼ú µî º¸´Ù ±¤¹üÀ§ÇÑ ÇコÄÉ¾î ¿¡ÄڽýºÅÛ°úÀÇ ÅëÇÕÀÌ ÁøÇàµÇ°í ÀÖ½À´Ï´Ù. ÀÌ ÅëÇÕÀ» ÅëÇØ ¿øÈ°ÇÑ µ¥ÀÌÅÍ °øÀ¯, Á¾ÇÕÀûÀΠȯÀÚ °ü¸®, ÀÇ·á Á¦°ø¾÷ü °£ÀÇ °øµ¿ ÀÇ»ç °áÁ¤ÀÌ °¡´ÉÇÕ´Ï´Ù.

½ÉÇ÷°ü Àå¾ÖÀÇ ¹ß»ý·ü°ú °ü·Ã »ç¸Á·ü Áõ°¡·Î ÀÎÇØ ¸ð¹ÙÀÏ ½ÉÀå ÅÚ·¹¸ÞÆ®¸®(MCT) ÀåÄ¡°¡ Á¦°øÇÏ´Â ÀÌÁ¡¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁ³À¸¸ç, ÀÌ´Â ¼¼°èÀÇ ¸ð¹ÙÀÏ ½ÉÀå ÅÚ·¹¸ÞÆ®¸® ½Ã½ºÅÛ ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀΰú µÇ¾î ÀÖ½À´Ï´Ù. ¿ø°Ý ÀÇ·áÀÇ È®´ë, ÀçÅà Äɾ ´ëÇÑ È¯ÀÚÀÇ ¼±È£, º´¿øÀÇ ÀçÀÔ¿øÀ» ÁÙÀÏ Çʿ伺 µîÀÇ ¿äÀο¡ ÀÇÇØ ¼¼°èÀÇ Çコ ÄÉ¾î ½Ã½ºÅÛÀ¸·Î ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ¼Ö·ç¼ÇÀÇ Ã¤¿ëÀÌ È®´ëµÇ°í ÀÖ´Â °ÍÀÌ, ¸ð¹ÙÀÏ ½ÉÀå ÅÚ·¹¸ÞÆ®¸® ½Ã½ºÅÛ ¼ö¿ä¸¦ È«º¸Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ °í·ÉÈ­ »çȸ·ÎÀÇ Àα¸Åë°èÇÐÀû º¯È­´Â ºÒ±ÔÄ¢ÇÑ ½ÉÀå ¸®µë ¹× ±âŸ ½ÉÀå ÀÌ»óÀ» °¨ÁöÇÒ ¼ö ÀÖ´Â Àå±â ¸ð´ÏÅ͸µ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. ¿þ¾î·¯ºí ¼¾¼­ ±â¼ú, ¹«¼± ¿¬°á ¹× µ¥ÀÌÅÍ ºÐ¼®ÀÇ ±â¼úÀû Áøº¸´Â ÀÌ·¯ÇÑ ½Ã½ºÅÛÀÇ Á¤È®¼º°ú È¿À²¼ºÀ» ´õ¿í ³ô¿© ½Ç½Ã°£ ¸ð´ÏÅ͸µ ¹× Áø´Ü¿¡ ±ÍÁßÇÕ´Ï´Ù. ±×·¯³ª ¾ö°ÝÇÑ ±ÔÁ¦ Á¤Ã¥°ú ǰÁú°ü¸® ±âÁذú ÇÔ²² Àü¹®ÀûÀÎ ±³À°°ú ±³À°ÀÇ ºÎÁ·ÀÌ 2024-2032³â ¿¹Ãø±â°£¿¡ À־ ½ÃÀå È®´ë¸¦ ¹æÇØÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ð¹ÙÀÏ ½ÉÀå ÅÚ·¹¸ÞÆ®¸® ½Ã½ºÅÛ ¼¼°è ½ÃÀå Á¶»ç¿¡¼­ °í·ÁÇÑ ÁÖ¿ä Áö¿ª¿¡´Â ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, ¶óƾ¾Æ¸Þ¸®Ä« ¹× ±âŸ ¼¼°è Áö¿ªÀÌ Æ÷ÇԵ˴ϴÙ. 2023³â¿¡´Â ºÏ¹Ì°¡ ¼öÀÍ Ãø¸é¿¡¼­ Áö¹èÀûÀÎ Áö¿ª ½ÃÀåÀ̾ú½À´Ï´Ù. ÀÌ ½ÃÀåÀÇ ¼ºÀåÀº ³ëÀÎ Àα¸ Áõ°¡, ½ÉÀå Áúȯ À¯º´·ü Áõ°¡, °Ç°­ °ü¸® ÁöÃâ Áõ°¡ µî ¿©·¯ ¿äÀÎÀ¸·Î ÀÎÇØ ¹ß»ýÇÕ´Ï´Ù. °Ô´Ù°¡, °Ç°­ °ü¸® ¼Ö·ç¼ÇÀÇ °³¼±À» Á¦°øÇÏ´Â ¼±µµÀûÀÎ ¼­ºñ½º Á¦°ø¾÷üÀÇ Á¸Àç´Â ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå È®´ë¸¦ ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¹Ý¸é ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀåÀº ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ ¼Óµµ·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ½Ä½À°üÀ̳ª ¿îµ¿ ºÎÁ·À¸·Î À̾îÁö´Â ¾É±â ½¬¿î ¶óÀÌÇÁ ½ºÅ¸ÀÏ Áõ°¡ µîÀÇ ¿äÀÎÀÌ ÀÌ Áö¿ª¿¡¼­ ½ÉÇ÷°ü ÁúȯÀÇ ¹ß»ý·ü »ó½Â¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼¼°èÀÇ ¸ð¹ÙÀÏ ½ÉÀå ÅÚ·¹¸ÞÆ®¸® ½Ã½ºÅÛ ½ÃÀå Á¤ÀÇ¿Í Á¶»çÀÇ ÀüÁ¦Á¶°Ç

  • Á¶»ç ¸ñÀû
  • ½ÃÀåÀÇ Á¤ÀÇ
  • Á¶»çÀÇ ÀüÁ¦Á¶°Ç
    • Æ÷ÇÔ°ú Á¦¿Ü
    • Á¦ÇÑ »çÇ×
    • °ø±ÞÃø ºÐ¼®
      • °¡¿ë¼º
      • ÀÎÇÁ¶ó
      • ±ÔÁ¦ ȯ°æ
      • ½ÃÀå °æÀï
      • °æÁ¦¼º(¼ÒºñÀÚÀÇ ½ÃÁ¡)
    • ¼ö¿äÃø ºÐ¼®
      • ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©
      • ±â¼úÀÇ Áøº¸
      • ȯ°æ¿¡ÀÇ ¹è·Á
      • ¼ÒºñÀÚÀÇ Àǽİú ¼ö¿ë
  • Á¶»ç ¹æ¹ý
  • Á¶»ç ´ë»ó³âµµ
  • ȯÀ² º¯È¯À²

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ¸ð¹ÙÀÏ ½ÉÀå ÅÚ·¹¸ÞÆ®¸® ½Ã½ºÅÛ ¼¼°è ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø(2022-2032³â)
  • Áö¿ªº° °³¿ä
  • ºÎ¹®º° °³¿ä
    • ¿ëµµº°
    • ÃÖÁ¾ ¿ëµµº°
  • ÁÖ¿ä µ¿Çâ
  • °æ±â ÈÄÅðÀÇ ¿µÇâ
  • ¾Ö³Î¸®½ºÆ®ÀÇ °á·Ð ¹× Á¦¾È

Á¦3Àå ¸ð¹ÙÀÏ ½ÉÀå ÅÚ·¹¸ÞÆ®¸® ½Ã½ºÅÛ ¼¼°è ½ÃÀå ¿ªÇÐ

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀåÀÇ °úÁ¦
  • ½ÃÀå ±âȸ

Á¦4Àå ¸ð¹ÙÀÏ ½ÉÀå ÅÚ·¹¸ÞÆ®¸® ½Ã½ºÅÛ ¼¼°è ½ÃÀå »ê¾÷ ºÐ¼®

  • Porter's Five Forces ¸ðµ¨
    • °ø±Þ±â¾÷ÀÇ Çù»ó·Â
    • ±¸¸ÅÀÚÀÇ Çù»ó·Â
    • ½Å±Ô ÁøÀÔ¾÷ÀÚÀÇ À§Çù
    • ´ëüǰÀÇ À§Çù
    • °æÀï ±â¾÷°£ °æÀï °ü°è
    • Porter's Five Forces ¸ðµ¨¿¡ ´ëÇÑ ¹Ì·¡Àû Á¢±Ù
    • Porter's Five Forces ¿µÇ⠺м®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ȯ°æ
    • ¹ý·ü
  • ÁÖ¿ä ÅõÀÚ ±âȸ
  • ÁÖ¿ä ¼º°ø Àü·«
  • ÆÄ±«Àû µ¿Çâ
  • ¾÷°è Àü¹®°¡ÀÇ ½ÃÁ¡
  • ¾Ö³Î¸®½ºÆ®ÀÇ °á·Ð ¹× Á¦¾È

Á¦5Àå ¸ð¹ÙÀÏ ½ÉÀå ÅÚ·¹¸ÞÆ®¸® ½Ã½ºÅÛ ¼¼°è ½ÃÀå ±Ô¸ð¡¤¿ëµµº° ¿¹Ãø(2022-2032³â)

  • ¸®µå º£À̽º
  • ÆÐÄ¡ º£À̽º

Á¦6Àå ¸ð¹ÙÀÏ ½ÉÀå ÅÚ·¹¸ÞÆ®¸® ½Ã½ºÅÛ ¼¼°è ½ÃÀå ±Ô¸ð¡¤¿ëµµº° ¿¹Ãø(2022-2032³â)

  • º´¿ø
  • ½ÉÀå¼¾ÅÍ
  • ±âŸ

Á¦7Àå ¸ð¹ÙÀÏ ½ÉÀå ÅÚ·¹¸ÞÆ®¸® ½Ã½ºÅÛ ¼¼°è ½ÃÀå ±Ô¸ð, Áö¿ªº° ¿¹Ãø(2022-2032³â)

  • ºÏ¹ÌÀÇ ¸ð¹ÙÀÏ ½ÉÀå ÅÚ·¹¸ÞÆ®¸® ½Ã½ºÅÛ ½ÃÀå
    • ¹Ì±¹
      • ¿ëµµÀÇ ³»¿ª ±Ô¸ð¿Í ¿¹Ãø(2022-2032³â)
      • ÃÖÁ¾ ¿ëµµÀÇ ³»¿ª ½ÃÀå ±Ô¸ð & ¿¹Ãø(2022-2032³â)
    • ij³ª´Ù ¸ð¹ÙÀÏ ½ÉÀå ÅÚ·¹¸ÞÆ®¸® ½Ã½ºÅÛ ½ÃÀå
  • À¯·´ÀÇ ¸ð¹ÙÀÏ ½ÉÀå ÅÚ·¹¸ÞÆ®¸® ½Ã½ºÅÛ ½ÃÀå
    • ¿µ±¹ÀÇ ¸ð¹ÙÀÏ ½ÉÀå ÅÚ·¹¸ÞÆ®¸® ½Ã½ºÅÛ ½ÃÀå
    • µ¶ÀÏ ¸ð¹ÙÀÏ ½ÉÀå ÅÚ·¹¸ÞÆ®¸® ½Ã½ºÅÛ ½ÃÀå
    • ÇÁ¶û½º ¸ð¹ÙÀÏ ½ÉÀå ÅÚ·¹¸ÞÆ®¸® ½Ã½ºÅÛ ½ÃÀå
    • ½ºÆäÀÎ ¸ð¹ÙÀÏ ½ÉÀå ÅÚ·¹¸ÞÆ®¸® ½Ã½ºÅÛ ½ÃÀå
    • ÀÌÅ»¸®¾Æ ¸ð¹ÙÀÏ ½ÉÀå ÅÚ·¹¸ÞÆ®¸® ½Ã½ºÅÛ ½ÃÀå
    • ±âŸ À¯·´ÀÇ ¸ð¹ÙÀÏ ½ÉÀå ÅÚ·¹¸ÞÆ®¸® ½Ã½ºÅÛ ½ÃÀå
  • ¾Æ½Ã¾ÆÅÂÆò¾ç ¸ð¹ÙÀÏ ½ÉÀå ÅÚ·¹¸ÞÆ®¸® ½Ã½ºÅÛ ½ÃÀå
    • Áß±¹ ¸ð¹ÙÀÏ ½ÉÀå ÅÚ·¹¸ÞÆ®¸® ½Ã½ºÅÛ ½ÃÀå
    • ÀεµÀÇ ¸ð¹ÙÀÏ ½ÉÀå ÅÚ·¹¸ÞÆ®¸® ½Ã½ºÅÛ ½ÃÀå
    • ÀϺ»ÀÇ ¸ð¹ÙÀÏ ½ÉÀå ÅÚ·¹¸ÞÆ®¸® ½Ã½ºÅÛ ½ÃÀå
    • È£ÁÖ ¸ð¹ÙÀÏ ½ÉÀå ÅÚ·¹¸ÞÆ®¸® ½Ã½ºÅÛ ½ÃÀå
    • Çѱ¹ÀÇ ¸ð¹ÙÀÏ ½ÉÀå ÅÚ·¹¸ÞÆ®¸® ½Ã½ºÅÛ ½ÃÀå
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç ¸ð¹ÙÀÏ ½ÉÀå ÅÚ·¹¸ÞÆ®¸® ½Ã½ºÅÛ ½ÃÀå
  • ¶óƾ¾Æ¸Þ¸®Ä« ¸ð¹ÙÀÏ ½ÉÀå ÅÚ·¹¸ÞÆ®¸® ½Ã½ºÅÛ ½ÃÀå
    • ºê¶óÁú ¸ð¹ÙÀÏ ½ÉÀå ÅÚ·¹¸ÞÆ®¸® ½Ã½ºÅÛ ½ÃÀå
    • ¸ß½ÃÄÚ ¸ð¹ÙÀÏ ½ÉÀå ÅÚ·¹¸ÞÆ®¸® ½Ã½ºÅÛ ½ÃÀå
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä« ¸ð¹ÙÀÏ ½ÉÀå ÅÚ·¹¸ÞÆ®¸® ½Ã½ºÅÛ ½ÃÀå
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¸ð¹ÙÀÏ ½ÉÀå ÅÚ·¹¸ÞÆ®¸® ½Ã½ºÅÛ ½ÃÀå
    • »ç¿ìµð¾Æ¶óºñ¾ÆÀÇ ¸ð¹ÙÀÏ ½ÉÀå ÅÚ·¹¸ÞÆ®¸® ½Ã½ºÅÛ ½ÃÀå
    • ³²¾ÆÇÁ¸®Ä«ÀÇ ¸ð¹ÙÀÏ ½ÉÀå ÅÚ·¹¸ÞÆ®¸® ½Ã½ºÅÛ ½ÃÀå
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¸ð¹ÙÀÏ ½ÉÀå ÅÚ·¹¸ÞÆ®¸® ½Ã½ºÅÛ ½ÃÀå

Á¦8Àå °æÀï Á¤º¸

  • ÁÖ¿ä ±â¾÷ÀÇ SWOT ºÐ¼®
  • ÁÖ¿ä ½ÃÀå Àü·«
  • ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • BioTelemetry, Inc.
      • ÁÖ¿ä Á¤º¸
      • °³¿ä
      • À繫(µ¥ÀÌÅÍÀÇ À̿밡´É¼º¿¡ µû¸§)
      • Á¦Ç° °³¿ä
      • ½ÃÀå Àü·«
    • ScottCare
    • Biotricity Inc.
    • Welch Allyn
    • Applied Cardiac Systems Inc.
    • Medicomp Inc.
    • Preventice Solutions
    • Telerhythmics LLC
    • Zoll Medical Corporation
    • iRhythm Technologies, Inc.

Á¦9Àå Á¶»ç °úÁ¤

  • Á¶»ç °úÁ¤
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • ºÐ¼®
    • ½ÃÀå ÃßÁ¤
    • °ËÁõ
    • ÃâÆÇ
  • Á¶»ç ¼Ó¼º
JHS 24.07.16

Global Mobile Cardiac Telemetry Systems Market is valued approximately USD 1047.72 million in 2023 and is anticipated to grow with a healthy growth rate of more than 12.72% over the forecast period 2024-2032. Mobile Cardiac Telemetry (MCT) systems are wearable devices that continuously monitor a person's heart activity for extended periods, detecting irregular rhythms and other cardiac events. These small devices transmit data wirelessly to healthcare providers, who analyze the information for abnormalities. MCT systems are crucial for diagnosing and managing heart conditions like atrial fibrillation, offering real-time monitoring and timely interventions for patients. The growing integration with healthcare ecosystems is a key trend that is supporting the growth of the Global Mobile Cardiac Telemetry Systems Market at a substantial rate. MCT systems are increasingly being integrated with broader healthcare ecosystems, including electronic health records (EHRs), telehealth platforms, and wearable technologies. This integration allows for seamless data sharing, comprehensive patient management, and collaborative decision-making among healthcare providers.

The rising incidence of cardiovascular disorders and related mortality rates has heightened awareness regarding the advantages offered by Mobile Cardiac Telemetry (MCT) devices, which is a major driving factor for the growth of the Global Mobile Cardiac Telemetry Systems Market. The growing adoption of remote patient monitoring solutions across healthcare systems worldwide, driven by factors such as telemedicine expansion, patient preference for home-based care, and the need to reduce hospital readmissions, fuels the demand for mobile cardiac telemetry systems. Additionally, the demographic shift towards an aging population amplifies the demand for long-term monitoring solutions capable of detecting irregular heart rhythms and other cardiac abnormalities. Technological advancements in wearable sensor technology, wireless connectivity, and data analytics further enhance the accuracy and efficacy of these systems, making them invaluable for real-time monitoring and diagnosis. However, the lack of professional training & education, along with stringent regulatory policies and quality control standards are expected to hinder market expansion over the 2024-2032 projection period.

The key regions considered for the global Mobile Cardiac Telemetry Systems Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, North America was the dominating regional market in terms of revenue. The growth of the market can be attributed to several factors including the growing elderly population, higher prevalence of cardiac disorders, and increased healthcare spending. Additionally, the presence of major service providers offering improved healthcare solutions is anticipated to drive market expansion during the forecast period. Whereas, the market in Asia Pacific is expected to grow at the fastest rate over the forecast period. Factors such as dietary habits and the growing adoption of sedentary lifestyles leading to physical inactivity are contributing to the rising incidence of cardiovascular diseases in the region.

Major market player included in this report are:

  • BioTelemetry, Inc.
  • ScottCare
  • Biotricity Inc.
  • Welch Allyn
  • Applied Cardiac Systems Inc.
  • Medicomp Inc.
  • Preventice Solutions
  • Telerhythmics LLC
  • Zoll Medical Corporation
  • iRhythm Technologies, Inc.

The detailed segments and sub-segment of the market are explained below:

By Application

  • Lead based
  • Patch Based

By End-use

  • Hospitals
  • Cardiac centers
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • RoMEA

Years considered for the study are as follows:

  • Historical year - 2022
  • Base year - 2023
  • Forecast period - 2024 to 2032

Key Takeaways:

  • Market Estimates & Forecast for 10 years from 2022 to 2032.
  • Annualized revenues and regional level analysis for each market segment.
  • Detailed analysis of geographical landscape with Country level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approach.
  • Analysis of competitive structure of the market.
  • Demand side and supply side analysis of the market

Table of Contents

Chapter 1. Global Mobile Cardiac Telemetry Systems Market Definition and Research Assumptions

  • 1.1. Research Objective
  • 1.2. Market Definition
  • 1.3. Research Assumptions
    • 1.3.1. Inclusion & Exclusion
    • 1.3.2. Limitations
    • 1.3.3. Supply Side Analysis
      • 1.3.3.1. Availability
      • 1.3.3.2. Infrastructure
      • 1.3.3.3. Regulatory Environment
      • 1.3.3.4. Market Competition
      • 1.3.3.5. Economic Viability (Consumer's Perspective)
    • 1.3.4. Demand Side Analysis
      • 1.3.4.1. Regulatory frameworks
      • 1.3.4.2. Technological Advancements
      • 1.3.4.3. Environmental Considerations
      • 1.3.4.4. Consumer Awareness & Acceptance
  • 1.4. Estimation Methodology
  • 1.5. Years Considered for the Study
  • 1.6. Currency Conversion Rates

Chapter 2. Executive Summary

  • 2.1. Global Mobile Cardiac Telemetry Systems Market Size & Forecast (2022- 2032)
  • 2.2. Regional Summary
  • 2.3. Segmental Summary
    • 2.3.1. By Application
    • 2.3.2. By End-use
  • 2.4. Key Trends
  • 2.5. Recession Impact
  • 2.6. Analyst Recommendation & Conclusion

Chapter 3. Global Mobile Cardiac Telemetry Systems Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Challenges
  • 3.3. Market Opportunities

Chapter 4. Global Mobile Cardiac Telemetry Systems Market: Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model
    • 4.1.7. Porter's 5 Force Impact Analysis
  • 4.2. PESTEL Analysis
    • 4.2.1. Political
    • 4.2.2. Economic
    • 4.2.3. Social
    • 4.2.4. Technological
    • 4.2.5. Environmental
    • 4.2.6. Legal
  • 4.3. Top investment opportunity
  • 4.4. Top winning strategies
  • 4.5. Disruptive Trends
  • 4.6. Industry Expert Perspective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Mobile Cardiac Telemetry Systems Market Size & Forecasts by Application 2022-2032

  • 5.1. Lead based
  • 5.2. Patch Based

Chapter 6. Global Mobile Cardiac Telemetry Systems Market Size & Forecasts by End-use 2022-2032

  • 6.1. Hospitals
  • 6.2. Cardiac centers
  • 6.3. Others

Chapter 7. Global Mobile Cardiac Telemetry Systems Market Size & Forecasts by Region 2022-2032

  • 7.1. North America Mobile Cardiac Telemetry Systems Market
    • 7.1.1. U.S. Mobile Cardiac Telemetry Systems Market
      • 7.1.1.1. Application breakdown size & forecasts, 2022-2032
      • 7.1.1.2. End-use breakdown size & forecasts, 2022-2032
    • 7.1.2. Canada Mobile Cardiac Telemetry Systems Market
  • 7.2. Europe Mobile Cardiac Telemetry Systems Market
    • 7.2.1. U.K. Mobile Cardiac Telemetry Systems Market
    • 7.2.2. Germany Mobile Cardiac Telemetry Systems Market
    • 7.2.3. France Mobile Cardiac Telemetry Systems Market
    • 7.2.4. Spain Mobile Cardiac Telemetry Systems Market
    • 7.2.5. Italy Mobile Cardiac Telemetry Systems Market
    • 7.2.6. Rest of Europe Mobile Cardiac Telemetry Systems Market
  • 7.3. Asia-Pacific Mobile Cardiac Telemetry Systems Market
    • 7.3.1. China Mobile Cardiac Telemetry Systems Market
    • 7.3.2. India Mobile Cardiac Telemetry Systems Market
    • 7.3.3. Japan Mobile Cardiac Telemetry Systems Market
    • 7.3.4. Australia Mobile Cardiac Telemetry Systems Market
    • 7.3.5. South Korea Mobile Cardiac Telemetry Systems Market
    • 7.3.6. Rest of Asia Pacific Mobile Cardiac Telemetry Systems Market
  • 7.4. Latin America Mobile Cardiac Telemetry Systems Market
    • 7.4.1. Brazil Mobile Cardiac Telemetry Systems Market
    • 7.4.2. Mexico Mobile Cardiac Telemetry Systems Market
    • 7.4.3. Rest of Latin America Mobile Cardiac Telemetry Systems Market
  • 7.5. Middle East & Africa Mobile Cardiac Telemetry Systems Market
    • 7.5.1. Saudi Arabia Mobile Cardiac Telemetry Systems Market
    • 7.5.2. South Africa Mobile Cardiac Telemetry Systems Market
    • 7.5.3. Rest of Middle East & Africa Mobile Cardiac Telemetry Systems Market

Chapter 8. Competitive Intelligence

  • 8.1. Key Company SWOT Analysis
  • 8.2. Top Market Strategies
  • 8.3. Company Profiles
    • 8.3.1. BioTelemetry, Inc.
      • 8.3.1.1. Key Information
      • 8.3.1.2. Overview
      • 8.3.1.3. Financial (Subject to Data Availability)
      • 8.3.1.4. Product Summary
      • 8.3.1.5. Market Strategies
    • 8.3.2. ScottCare
    • 8.3.3. Biotricity Inc.
    • 8.3.4. Welch Allyn
    • 8.3.5. Applied Cardiac Systems Inc.
    • 8.3.6. Medicomp Inc.
    • 8.3.7. Preventice Solutions
    • 8.3.8. Telerhythmics LLC
    • 8.3.9. Zoll Medical Corporation
    • 8.3.10. iRhythm Technologies, Inc.

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦